CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 38,622	$ 14,987
General and administrative	14,615	8,035
Total operating expenses	53,237	23,022
Loss from operations	(53,237)	(23,022)
Other income (expense):
Interest income	1,830	65
Other expense	(79)	(3)
Total other income	1,751	62
Net loss before income taxes	(51,486)	(22,960)
Provision for income taxes	25	3
Net loss	(51,511)	(22,963)
Comprehensive loss:
Net loss	(51,511)	(22,963)
Other comprehensive loss:
Unrealized loss on securities	(407)	(59)
Comprehensive loss	$ (51,918)	$ (23,022)
Net loss per share, basic	$ (2.10)	$ (1.87)
Net loss per share, diluted	$ (2.10)	$ (1.87)
Weighted-average shares of common stock outstanding, basic	24,472,104	12,293,629
Weighted-average shares of common stock outstanding, diluted	24,472,104	12,293,629